Effect of the donor CMV status on CMV reactivation after allogeneic transplantation

被引：0
|
作者：
Nürnberger, W
Krempe, C
Steinhagen, G
Adams, O
Göbel, U
机构：
[1] Univ Dusseldorf, Dep Pediat Hematol & Oncol, D-4000 Dusseldorf, Germany
[2] Univ Dusseldorf, Inst Med Microbiol & Virol, D-4000 Dusseldorf, Germany
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
214
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] CMV and EBV Reactivation after Allogeneic Transplantation
    Butler, Andrew
    Thurston, Andrew
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S244 - S244
  • [2] Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral Reactivation after Allogeneic Stem Cell Transplantation in CMV-Seropositive Recipients
    Pietersma, Floor L.
    van Dorp, Suzanne
    Minnema, Monique C.
    Kuball, Jurgen
    Meijer, Ellen
    Schuurman, Rob
    van Baarle, Debbie
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (07) : E144 - E148
  • [3] Donor and recipient CMV status and the risk of CMV activation after allogeneic stem cell transplantation.
    Juvonen, E
    Ruutu, T
    Eriksson, B
    Remes, K
    Volin, L
    Remberger, M
    Parkkali, T
    Hägglund, H
    Ringdén, O
    [J]. BLOOD, 2001, 98 (11) : 396A - 396A
  • [4] THE EFFECT OF DONOR CYTOMEGALOVIRUS (CMV) SEROLOGIC STATUS ON CMV REACTIVATION AND SURVIVAL IN PATIENTS UNDERGOING ALLOGENIC STEM CELL TRANSPLANTATION
    Vega, J.
    Vatca, M.
    Mikulandric, N.
    Neme, K.
    Hanbali, A.
    Janakiraman, N.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 109 - 109
  • [5] Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT)
    Huang, Yao-Ting
    Foldi, Julia
    Xiao, Kun
    Chung, Dick
    Neofytos, Dionysios
    Kolitsopoulos, Yovanna
    Maloy, Molly
    Giralt, Sergio
    Papadopoulos, Esperanza
    Jakubowski, Ann A.
    Papanicolaou, Genovefa
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S302 - S303
  • [6] Donor CMV status influence on the outcome of allogeneic stem cell transplantation (HSCT)
    Ljungman, P.
    Brand, R.
    de la Camaro, R.
    Cordonnier, C.
    Einsele, H.
    Styczynski, J.
    Ward, K.
    Cesaro, S.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S54 - S55
  • [7] Analysis of Anti-CMV T-Cell Immunity and CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation
    Chen, George
    Zhang, Yali
    Tario, Joseph Dennis
    Herko, Amanda
    Pan, Przespolewski Dalin
    Mellors, Patrick
    Ho, Christine
    Balderman, Sophia R.
    Ross, Maureen
    Brix, Liselotte
    Wallace, Paul K.
    McCarthy, Philip L.
    Hahn, Theresa
    [J]. BLOOD, 2017, 130
  • [8] Generation and administration of CMV pp65-specific donor T-cell lines for treatment of CMV reactivation after allogeneic stem cell transplantation
    Meij, P.
    Zandvliet, M. L.
    van der Heiden, P. L. J.
    Jedema, I.
    Egmond, E. M.
    Cox, L. M. P.
    de Meent, M. van
    Bongaerts, R.
    Hoogstraten, C.
    Guchelaar, H. J.
    Willemze, R.
    Falkenburg, J. H. F.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 39 : S28 - S29
  • [9] How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
    Einsele, Hermann
    Ljungman, Per
    Boeckh, Michael
    [J]. BLOOD, 2020, 135 (19) : 1619 - 1629
  • [10] Understanding the relationship between donor CMV serostatus and the effect of viral reactivation on relapse in lymphoid malignancies following allogeneic hematopoietic cell transplantation in CMV seropositive recipients
    Murthy, H.
    Miladinovic, B.
    Nishihori, T.
    Ayala, E.
    Alsina, M.
    Betts, B.
    Fernandez, H.
    Khimani, F.
    Locke, F.
    Mishra, A.
    Nieder, M.
    Perez, L.
    Pidala, J.
    Kumar, A.
    Anasetti, C.
    Kharfan-Dabaja, M.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S205 - S206
12345